Przegla̜d Gastroenterologiczny最新文献

{"title":"Identifying and evaluating factors related to feeding disorders in children using the path analysis method.","authors":"Amirhossein Hosseini, Saeedeh Sistani, Arsalan Sabooree, Maryam Mollaei, Seyed Ali Mofidi, Naghi Dara, Aliakbar Sayyari, Mahmoud Hajipour","doi":"10.5114/pg.2025.148478","DOIUrl":"10.5114/pg.2025.148478","url":null,"abstract":"<p><strong>Introduction: </strong>Pediatric feeding disorders (PFDs) refer to the impaired consumption of food that is inappropriate for a child's age group. Understanding the causes and influencing factors of PFDs is crucial for managing these disorders.</p><p><strong>Aim: </strong>This study aimed to analyze the factors associated with PFDs using the path analysis method.</p><p><strong>Material and methods: </strong>A cross-sectional study was conducted on 500 children aged 6 months to 18 years who visited gastroenterology and child nutrition clinics. Data were collected through interviews with mothers and physicians, and analyzed using the path analysis method. The model included latent variables such as feeding disorders and birth status, as well as observed variables such as socio-economic status, food group, feeding practices, destructive behaviors, sleep, and body mass index (BMI) <i>z-</i>score.</p><p><strong>Results: </strong>We conducted three path analyses. The socio-economic status (SES) directly and indirectly plays a role in feeding disorders in children; the total effect on feeding disorders was positive (β = 0.075). The direct effect of SES on the intake of food groups was positive (β = 0.190), on BMI <i>z-</i>score was positive (β = 0.100), and it was generally associated with a negative effect on feeding disorders (β = -0.05). The total effect of destructive behaviors on body mass was negative (β = 0.262) and on feeding disorders was positive (β = -0.041). Children who had regular sleep had significantly fewer feeding disorders (total effect: -0.369).</p><p><strong>Conclusions: </strong>Socio-economic status, destructive behaviors, sleep, and BMI were found to be factors influencing eating disorders in children.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 1","pages":"55-61"},"PeriodicalIF":1.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11966512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143795996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New challenges in the management of inflammatory bowel disease: a case study.","authors":"Grazyna Piotrowicz, Agata Rudnik, Mariusz Śmigielski, Adam Piotrowicz, Magdalena Rzeszutek, Agnieszka Klufczyńska","doi":"10.5114/pg.2024.139242","DOIUrl":"10.5114/pg.2024.139242","url":null,"abstract":"","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 1","pages":"107-110"},"PeriodicalIF":1.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11966519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143795974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of glutamate dehydrogenase (GLDH) as a diagnostic and prognostic marker in drug-induced liver injury.","authors":"Omkolsoum Alhaddad, Maha Elsabaawy, Amany Salah, Olfat Hendy, Dalia Elsabaawy, Mohamed Mazaly, Aliaa Sabry","doi":"10.5114/pg.2024.143153","DOIUrl":"10.5114/pg.2024.143153","url":null,"abstract":"<p><strong>Introduction: </strong>Drug-induced liver injury (DILI) is a significant clinical event, associated with notable morbidity and mortality. The paucity of DILI diagnostic and/or prognostic biomarkers still represents an unmet need.</p><p><strong>Aim: </strong>We aimed to evaluate the role of glutamate dehydrogenase (GLDH) as a diagnostic and prognostic marker in patients with DILI.</p><p><strong>Material and methods: </strong>A case-control study was conducted on 40 acute DILI patients and 40 acute viral hepatitis patients, in addition to a healthy control group (20). Clinical and laboratory characteristics were evaluated including ELISA assay of GLDH, along with RUCAM score and liver biopsy whenever feasible. All cases were followed up for 6 months.</p><p><strong>Results: </strong>Diclofenac was the most incriminated drug in DILI (40%). GLDH was higher in the DILI than control and acute viral hepatitis patients (18.5 ±10.4, 0.89 ±0.6, 1.5 ±1.2 U/l) respectively (<i>p</i> < 0.001). Moreover, it was strongly correlated with aminotransferases, alkaline phosphatase, prothrombin concentration (PC), and bilirubin. The GLDH level in hepatocellular injury was 24.5 ±4.4 U/l, while it was 1.5.5 ±0.6 U/l in mixed and 3.5 ±1.1 U/l in cholestatic injury (<i>p</i> < 0.001). The AUC for GLDH level was 0.936 (<i>p</i> < 0.001) at a cutoff of 2.1 U/l, where the sensitivity was 90%, specificity 85%, positive predictive value 91.08% and negative predictive value 83.31% in prediction of DILI. GLDH was higher in patients who died than those who survived (32.36 ±1.1 vs. 15.36 ±10.1 U/l, respectively) (<i>p</i> = 0.000). Multivariate analysis defined age, bilirubin, and GLDH as independent predictors of poor outcomes in DILI.</p><p><strong>Conclusions: </strong>GLDH is a highly specific, simple, real-time, and inexpensive diagnostic and prognostic marker of DILI and shows potential to address this unmet need.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 2","pages":"165-172"},"PeriodicalIF":1.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Consumption patterns of the frequently used drugs and their impact on the gastric cancer epidemiological indices in Ukraine, 2014-2021.","authors":"Yevgen O Protas, Valeriia Haysanovska, Olha V Makarenko","doi":"10.5114/pg.2025.149964","DOIUrl":"10.5114/pg.2025.149964","url":null,"abstract":"<p><strong>Introduction: </strong>Gastric cancer remains one of the leading causes of cancer-related death. Many frequently used drugs (proton pump inhibitors (PPI), statins, metformin, and non-steroidal anti-inflammatory drugs (NSAID)) can play a role in the development of gastric cancer or attenuate <i>Helicobacter pylori</i>'s adhesion (cysteine derivatives).</p><p><strong>Aim: </strong>To analyse the patterns and dynamics of consumption of PPIs, statins, metformin, NSAIDs and cysteine derivatives in Ukraine in comparison with global trends, and to explore their potential impact on the gastric cancer morbidity in Ukraine.</p><p><strong>Material and methods: </strong>The consumption of PPIs, statins, metformin, NSAIDs, and cysteine derivatives (by mean of daily defined doses (DDDs)/100 000 habitants per year, 2014-2020) and gastric cancer epidemiological indices, such as the incidence rate (per 100 000 habitants per year, 2014-2021), main forms, and age prevalence, were estimated in Ukraine.</p><p><strong>Results: </strong>Levels of PPI, statins, metformin, NSAID, and cysteine derivative consumption increased by 98.61% (<i>p</i> < 0.0001), 199.15% (<i>p</i> < 0.0001), 141.29% (<i>p</i> < 0.0001), 23.51% (<i>p</i> < 0.0001), and 42.06% (<i>p</i> < 0.0001), respectively, in 2020 compared to 2014 whereas the gastric cancer incidence rate decreased by 26.56% (<i>p</i> < 0.0001) in 2021 compared to 2014 in Ukraine.</p><p><strong>Discussion: </strong>The gastric cancer incidence rate decreased, and its epidemiological structure was stable, in Ukraine between 2014 and 2021. The consumption of PPIs, statins, metformin, NSAIDs, and cysteine derivatives might play a complex role in the development of gastric cancer.</p><p><strong>Conclusions: </strong>The trends of the gastric cancer incidence rate, its epidemiological structure, and the increased consumption of PPIs, statins, metformin, NSAIDs, and cysteine derivatives in Ukraine between 2014 and 2021 correspond to global trends. Statins, metformin, NSAIDs, and cysteine derivatives might lead to a decline in gastric cancer in the population despite the increased consumption of PPIs.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 3","pages":"305-310"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Summary of gastroscopy quality indicators applicable in clinical practice.","authors":"Mikołaj Machaj, Krzysztof Budzyń, Gustaw Błaszczyński, Tomasz Romańczyk","doi":"10.5114/pg.2025.154599","DOIUrl":"10.5114/pg.2025.154599","url":null,"abstract":"<p><p>Despite advances in medicine, upper gastrointestinal cancers remain a significant global concern. In Poland, regardless of the increase in performed esophagogastroduodenoscopies, the rate of missed cancers is around 6%. This is related to the insufficient quality measures during the performed examinations. Our paper discusses key endoscopy quality indicators that can enhance the detection of precancerous lesions and cancers. We categorized the indicators into three sections: pre-procedural (fasting time, premedication), intra-procedural (sedation, photodocumentation, virtual chromoendoscopy, quality metrics, biopsy sampling) and post-procedural (coordinated care, training). Some of them, such as chromoendoscopy and premedication in the upper segment, have been widely studied and popularized in recent years. For several years, we have had strict protocols on how to take specimens depending on the condition. Most of the assumptions presented can be easily implemented into daily routine practice, which can improve health care. These are successfully, routinely used in Japan and Korea. We believe that a collective improvement in the quality of esophagogastroduodenoscopies performed will increase the detection rates of precancerous lesions and early cancers. However, further research in this area is still needed.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 3","pages":"241-250"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and safety of faecal microbiota transplantation (FMT) in recurrent <i>Clostridioides difficile</i> infection: results of a single-centre retrospective study.","authors":"Marcin Bzdyra, Edyta M Tulewicz-Marti, Anna Przepióra, Konrad Lewandowski, Grażyna Rydzewska","doi":"10.5114/pg.2025.154701","DOIUrl":"10.5114/pg.2025.154701","url":null,"abstract":"<p><strong>Introduction: </strong>Studies have indicated the high effectiveness of faecal microbiota transplantation (FMT) in the treatment of recurrent <i>Clostridioides difficile</i> infection (rCDI). However, there is still a lack of data from different subpopulations regarding FMT and the factors related to it.</p><p><strong>Aim: </strong>The aim of the study was to retrospectively evaluate the efficacy and safety of FMT in rCDI.</p><p><strong>Material and methods: </strong>In all cases, FMT was performed using a nasoenteric tube. A good response following a single FMT was considered an improvement, whereas requiring more than one FMT was considered a suboptimal response.</p><p><strong>Results: </strong>In the analysed period, FMT was performed on a total of 98 patients, including 74 with rCDI (of whom 23 received 2 FMTs, 6 received 3 FMTs, and 1 received 5 FMTs). The average age of the patients was 68 years. 42 (56%) patients were women, 41 (55.4%) had previously used antibiotics, 2 (2.7%) had used steroids, and 4 (5.4%) had used proton pump inhibitors (PPI). Following the first FMT procedure, clinical improvement was observed in 44 (59.4%) patients. The odds of a suboptimal effect of the therapy (needing more than 1 FMT) were associated with prior use of metronidazole. Among all analysed factors, cardiovascular risk factors (such as hypertension and hyperlipidaemia) were associated with a threefold increased likelihood of requiring more than 1 FMT (<i>p</i> = 0.038).</p><p><strong>Conclusions: </strong>In our study, FMT was found to be an effective and safe treatment of recurrent CDI. Use of metronidazole was identified as a risk factor for a suboptimal response to FMT in the studied cohort.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 3","pages":"330-334"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role and therapeutic effectiveness of <i>Plantago ovata</i> husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 2. Clinical use of psyllium husk in the treatment of constipation and diarrhea.","authors":"Justyna Przybyszewska, Andrzej Kuźmiński, Michał Przybyszewski, Cezary Popławski","doi":"10.5114/pg.2024.141832","DOIUrl":"10.5114/pg.2024.141832","url":null,"abstract":"<p><p>The results of numerous clinical studies available in the literature allow us to conclude that the fiber deserving the name of the gold standard in regulating bowel movements is the psyllium husk obtained from <i>Plantago ovata</i>. The physicochemical properties of psyllium, related to its ability to form a gel in an aqueous environment and its ability to retain water in this mucous-gel structure, mean that preparations containing <i>P. ovata</i> husk show therapeutic effects in both constipation (including occasional and chronic) and diarrhea (acute and chronic). Moreover, the results of studies and clinical experiments indicate that the use of <i>P. ovata</i> husk in the treatment of bowel disorders is distinguished by significantly higher efficacy compared to pharmacological preparations such as sodium docusate or loperamide. This article presents the evidence available in the recent literature on the therapeutic potential and possible mechanisms of action of <i>Plantago ovata</i> husk in the treatment of constipation and diarrhea.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 2","pages":"121-126"},"PeriodicalIF":1.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical manifestation of B-cell lymphoma presenting as acute pancreatitis.","authors":"Miłosz Caban, Barbara Włodarczyk, Ewa Małecka-Wojciesko","doi":"10.5114/pg.2025.154597","DOIUrl":"10.5114/pg.2025.154597","url":null,"abstract":"","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 3","pages":"335-337"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic and therapeutic guidelines for pancreatic cystic tumors: recommendations of Polish Pancreatic Club experts.","authors":"Łukasz Durko, Michał Lipiński, Krystian Adrych, Jarosław Daniluk, Andrzej Dąbrowski, Adam Durczyński, Anita Gąsiorowska, Stanisław Głuszek, Marek Hartleb, Piotr Hogendorf, Mateusz Jagielski, Kamil Jaszczuk, Grażyna Jurkowska, Katarzyna Kuśnierz, Ewa Małecka-Wojciesko, Agnieszka Mądro, Sławomir Mrowiec, Ewa Nowakowska-Duława, Grzegorz Oracz, Marcin Polkowski, Jarosław Reguła, Grażyna Rydzewska, Anna Wiechowska-Kozłowska, Renata Talar-Wojnarowska","doi":"10.5114/pg.2025.154686","DOIUrl":"10.5114/pg.2025.154686","url":null,"abstract":"<p><p>The diagnosis, treatment, and follow-up of pancreatic cystic tumors require a careful expert consensus approach due to their diverse nature and variable potential for malignancy. In view of these challenges, a panel of experts from the Polish Pancreatic Club has developed comprehensive recommendations. These guidelines are based on the most recent literature data and reflect current advances in diagnostic imaging and therapeutic interventions. The panel conducted an extensive review of available publications, meticulously formulating each recommendation and subsequently voting on them using the GRADE system (providing the quality of evidence and recommendation strength for each statement). The guidelines emphasize the importance of advanced imaging modalities (such as computed tomography, magnetic resonance, and endoscopic ultrasound), fine needle aspiration biopsy in selected situations and applicable laboratory tests to improve diagnostic accuracy. Furthermore, treatment strategies are carefully tailored to match individual risk profiles and specific lesion characteristics. Management options range from conservative treatment with routine follow-up examinations to surgical interventions when clinical indications require such an approach. Overall, these expert recommendations provide clinicians with a valuable and reliable framework, firmly anchored in current scientific data and consensus among specialists, for effectively managing pancreatic cystic tumors in clinical practice. Ultimately, these guidelines will lead to improved patient outcomes.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 3","pages":"223-240"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unrecognized Wernicke's encephalopathy during pregnancy induced by hyperemesis gravidarum.","authors":"Emilija Nikolovska Trpchevska, Beti Todorovska, Meri Trajkovska, Dafina Nikolova, Elena Ristovska Curakova, Mia Rusomanova, Stefan Pejkovski, Svetozar Antovikj, Dragica Nikolova, Anita Nanushevska","doi":"10.5114/pg.2025.154605","DOIUrl":"10.5114/pg.2025.154605","url":null,"abstract":"","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"20 3","pages":"338-339"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}